Accrol Group Holdings appoint Chris Welsh as Chief Financial Officer

Accrol Group Holdings plc

Accrol Group Holdings (LON:ACRL), the UK’s leading independent tissue converter, has announced that Chris Welsh has today joined the Board as Chief Financial Officer (“CFO”).

As detailed in the HY23 Results announcement, Chris succeeds Richard Newman, who has now resigned as CFO and stepped down from the Board but, to ensure a smooth transition, has agreed to remain with the Company until the FY23 audit process is completed and the Final Results are released.

Chris joined the business in October 2022, as part of the Board’s succession planning. Before his move to Accrol, Chris held several senior finance roles at the multinational chemical manufacturing group, Ineos, most latterly as Head of Financial Reporting at the Enterprises Division.

Chris is a Chartered Accountant, who qualified with PwC in 2015.

Gareth Jenkins, Accrol Group Holdings Chief Executive Officer, said:

“We are delighted to welcome Chris to the Board. Since joining Accrol last year, he has been operating at the highest standard, demonstrating the commitment, energy and acumen which will help deliver our strategic objectives.

“I would also like to take this opportunity to thank Richard for his significant contribution to the Group. On appointment, he was tasked with transforming the finance function of the business, which he has achieved. Richard hands over to Chris a much strengthened finance team and infrastructure, capable of serving a much larger business.”

Further information relating to Christopher Welsh

In accordance with Schedule 2(g) of the AIM rules, Christopher (“Chris”) James Welsh (aged 33) holds or has held in the past five years the following directorships:

Current directorships

·Accrol UK Limited
·LTC Parent Ltd
·John Dale Holdings Limited
·Leicester Tissue Company Limited
·Art Tissue Ltd
·Accrol Papers Limited
·Accrol Holdings Limited
·John Dale Limited

Chris holds no shares in the Accrol Group Holdings.

There is no further information on Chris required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Accrol Group publishes Shareholder Circular for Scheme Document and Offer Terms

Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.

Accrol Group Holdings plc: Strong performance in H1 FY24, expects to outperform in FY25

Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Accrol to Release Half Year results on 30 January; online investor presentation on 2 February

Accrol Group will release its Half Year Results on 30 January 2024. Join their online investor presentation and Q&A session on 2 February 2024.

Accrol acquires Severn Delta, strengthening wet wipe segment and expanding product range

Accrol Group has completed the acquisition of Severn Delta, expanding their product range and market share in the wet wipe segment.

Search

Search